Federal Register / Vol. 63, No. 119 / Monday, June 22, 1998 / Notices 33935

FOR FURTHER INFORMATION CONTACT:

Aydin O ̈ rstan, Center for Food Safety

and Applied Nutrition (HFS–215), Food

and Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3076.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 721(d)(1) (21 U.S.C. 379e(d)(1))),

notice is given that a color additive

petition (CAP 8C0257) has been filed by

EM Industries, Inc., 7 Skyline Dr.,

Hawthorne, NY 10532. The petition

proposes to amend the color additive

regulations to provide for the safe use of

synthetic iron oxide to color ingested

drugs at levels higher than the current

limit and to provide for the safe use of

mica to color ingested drugs.

The agency has determined under 21

CFR 25.32(r) that this action is of a type

that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

Dated: June 10, 1998.

Laura M. Tarantino,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 98–16504 Filed 6–19–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food And Drug Administration

[Docket No. 98F–0432]

Ticona; Filing of Food Additive Petition

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is announcing

that Ticona has filed a petition

proposing that the food additive

regulations be amended to provide for

the safe use of chromium oxide green,

Cr2O3 (C.I. Pigment Green 17) as a

colorant for polymers intended for use

in contact with food.

FOR FURTHER INFORMATION CONTACT: Vir

D. Anand, Center for Food Safety and

Applied Nutrition (HFS–215), Food and

Drug Administration, 200 C St. SW.,

Washington, DC 20204, 202–418–3081.

SUPPLEMENTARY INFORMATION: Under the

Federal Food, Drug, and Cosmetic Act

(sec. 409(b)(5) (21 U.S.C. 348(b)(5))),

notice is given that a food additive

petition (FAP 8B4603) has been filed by

Ticona, c/o Keller and Heckman, 1001

G St. NW., suite 500 West, Washington,

DC 20001. The petition proposes to

amend the food additive regulations to

provide for the safe use of chromium

oxide green, Cr2O3 (C.I. Pigment Green

17) as a colorant for polymers intended

for use in contact with food. The agency

has determined under 21 CFR 25.32(i)

that this action is of the type that does

not individually or cumulatively have a

significant effect on the human

environment. Therefore, neither an

environmental assessment nor an

environmental impact statement is

required.

Dated: June 4, 1998.

Laura M. Tarantino,

Acting Director, Office of Premarket

Approval, Center for Food Safety and Applied

Nutrition.

[FR Doc. 98–16505 Filed 6–19–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Resources and Services

Administration

Agency Information Collection

Activities: Proposed Collection:

Comment Request

In compliance with the requirement

for opportunity for public comment on

proposed data collection projects

(section 3506(c)(2) (A) of Title 44,

United States Code, as amended by the

Paperwork Reduction Act of 1995, Pub.

L. 104–13), the Health Resources and

Services Administration (HRSA) will

publish periodic summaries of proposed

projects being developed for submission

to the Office of Management and Budget

under the Paperwork Reduction Act of

1995. To request more information on

the proposed project or to obtain a copy

of the data collection plans, call the

HRSA Reports Clearance Officer on

(301) 443–1129.

Comments are invited on: (a) whether

the proposed collection of information

is necessary for the proper performance

of the functions of the Agency,

including whether the information shall

have practical utility; (b) the accuracy of

the Agency’s estimate of the burden of

the proposed collection of information;

(c) ways to enhance the quality, utility,

and clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including the use of

automated collection techniques or

other forms of information technology.

Proposed Project: Application for NHSC

Recruitment and Retention Assistance

and Waiver of NHSC Site Bill—(in use

Without Approval)

The National Health Service Corps

(NHSC) of the HRSA’s Bureau of

Primary Health Care, assists

underserved communities through the

development, recruitment, and retention

of primary health care clinicians

dedicated to serving people in health

professional shortage areas.

The Application for NHSC

Recruitment and Retention Assistance

submitted by sites or clinicians requests

information on the practice site,

sponsoring agency, recruitment contact,

staffing levels, service users, site’s 5-

year infant mortality or low birth rate

averages, and next nearest site.

Assistance in completing the

application may be obtained through the

appropriate State Primary Care Offices,

State Primary Care Associations and

HRSA field offices. A form requesting a

waiver of the NHSC site bill for a

calendar year may be requested at the

same time. The information on the

application is used for determining

eligibility of sites and to verify the need

for NHSC providers. Sites must submit

applications annually or when they

need a provider. The request for a

waiver is used to suspend the

educational and loan repayment costs of

NHSC providers.

Estimates of annualized reporting

burden are as follows:

Type of report Number of

respondents

Hours per

response

Total burden hour

Application ................................................................................................................................................ 1,000 .75 750

Waiver ...................................................................................................................................................... 738 4 2,952

Total ............................................................................................................................................... 1,000 .................... 3,702
33936 Federal Register / Vol. 63, No. 119 / Monday, June 22, 1998 / Notices

Send comments to HRSA Reports

Clearance Officer, Room 14–36,

Parklawn Building, 5600 Fishers Lane,

Rockville, MD 20857. Written comments

should be received within 60 days of

this notice.

Dated: June 15, 1998.

Jane Harrison,

Director, Division of Policy Review and

Coordination.

[FR Doc. 98–16452 Filed 6–19–98; 8:45 am]

BILLING CODE 4160–15–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; Substance Abuse

Treatment Study

SUMMARY: Under the provisions of

Section 3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the National

Institute on Alcohol Abuse and

Alcoholism (NIAAA), National

Institutes of Health (NIH) has submitted

to the Office of Management and Budget

(OMB) a request to review and approve

the information collection listed below.

This proposed information collection

was previously in the Federal Register

on October 27, 1997, and allowed 60

days for public comment. There were no

requests for additional information

about this data collection activity, no

public comments were received. The

purpose of this notice is to allow an

additional 30 days for public comment.

The NIH may not conduct or sponsor,

and the respondent is not required to

respond to, an information collection

that has been extended, revised, or

implemented on or after December 31,

1999, unless it displays a currently valid

OMB control number.

Proposed Collection: Title: Substance

Abuse Treatment Study. Type of

Information Collection Request: New.

Need and Use of Information Collection:

The information proposed for collection

in this study will be used by the NIAAA

to observe group treatment at up to 20

treatment facilities. At each facility,

directors will be asked to provide

information about treatment practices

and about the client population. At each

facility at least seven members of the

treatment staff will be asked to provide

information about their treatment

activities, personal experiences and

training. At each facility eight treatment

groups will be observed. The group

leader will be asked to complete a

questionnaire about the observed

session and other client demographics.

At least seven group members will also

be asked to complete a questionnaire

about the observed group session. The

target population for the study is a

group of outpatient public and private

providers that will include group

treatment as part of their overall plan of

clinical therapeutics.

The specific aim of this study is the

testing of instruments and

methodologies for the systematic

measurement of the content, process,

and context of group treatment.

Frequency of Response: On occasion.

Affected Public: Individuals. Type of

Respondents: American adults.

Estimated Number of Respondents:

1440. Estimated Number of Responses

per Respondent: 1. Average Burden

Hours per Response: .3465. And

Estimated Total Annual Burden Hours

Requested: 449. The annualized cost to

respondents is estimated at: $5,676.

There are no Capital Costs to report.

There are no Operating or Maintenance

Costs to report.

The annual burden estimates are as

follows:

Type and number of respondents

Responses

per respondent

Total responses Hours Total hours

Facility Director—20 ......................................................................................... 1 20 .75 15

Group Leader—80 ............................................................................................ 2 160 .334 55

Treatment Staff—140 ....................................................................................... 1 140 .334 48

Group Member—560 ........................................................................................ 2 1120 .334 381

Total Number of Respondents .................................................................. ........................ 1440 ........................ ........................

Total Number of Responses ..................................................................... ........................ 1440 ........................ ........................

Total Hours ................................................................................................ ........................ 499 ........................ ........................

Request for Comments: Comments are

invited on: (a) whether the proposed

collection is necessary, including

whether the information has practical

use; (b) ways to enhance the clarity,

quality, and use of the information to be

collected; (c) the accuracy of the agency

estimate of burden of the proposed

collection; and (d) ways to minimize the

collection burden of the respondents.

Send written comments to Dr. Margaret

Mattson, Treatment Research Branch,

Division of Clinical and Prevention

Research (DCPR), NIAAA, NIH, Willco

Bldg., Suite 505, 6000 Executive Blvd.,

Bethesda, Maryland 20892–7003.

Direct Comments to OMB: Written

comments and/or suggestions regarding

the item(s) contained in this notice,

especially regarding the estimated

public burden and associated response

time, should be directed to the Office of

Management and Budget, Office of

Regulatory Affairs, New Executive

Office Building, Room 10235,

Washington, D.C. 20503, Attention:

Desk Officer for NIH.

FOR FURTHER INFORMATION CONTACT: To

request more information on the

proposed project or to obtain a copy of

the data collection plans, contact Dr.

Margaret Mattson, Treatment Research

Branch, Division of Clinical and

Prevention Research, NIAAA, NIH,

Willco Bldg., Suite 505, 6000 Executive

Blvd., Bethesda, Maryland 20892–7003,

or call non-toll-free number (301) 443–

0638.

Comments Due Date: Comments

regarding this information collection are

best assured of having their full effect if

received on or before July 22, 1998.

Dated: April 6, 1998.

Martin K. Trusty,

Executive Officer, NIAAA.

[FR Doc. 98–16424 Filed 6–19–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Submission for OMB Review;

Comment Request; American Stop

Smoking Intervention Study for Cancer

Prevention (ASSIST) Final Evaluation:

‘‘Tobacco use Supplement to the

1998–1999 Current Population Survey’’

SUMMARY: Under the provisions of

Section 3506(c)(2)(A) of the Paperwork

Reduction Act of 1995, the National

Cancer Institute (NCI), the National